Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Clinical data reported for litoxetine in mixed urinary incontinence

March 19, 2019

Veverimer phase III results for metabolic acidosis associated with chronic kidney disease

March 15, 2019

Dicerna enrolling in phase II study of DCR-PHXC for primary hyperoxaluria

March 11, 2019

Eli Lilly and Company synthesizes PDE1 inhibitors

March 4, 2019

Lilly synthesizes new phosphodiesterase PDE1 inhibitors

Feb. 26, 2019

Imarikiren improves albuminuria in patients with type 2 diabetes

Feb. 22, 2019

DDR1 inhibitor seen to prevent renal function loss in mice

Feb. 21, 2019

Positive data presented from phase II PHOENIX study of bardoxolone methyl

Feb. 21, 2019

Dual complement inhibition by CRIg/FH shows renoprotective effect in ischemia reperfusion injury

Feb. 18, 2019

New phase III study of empagliflozin assesses cardio-renal outcomes in chronic kidney disease

Feb. 8, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.